Table 3 Prevalence and awareness, treatment, and control proportions of biological cardiovascular health metrics in total sample and by sex (n = 5026)

 Prevalence

3374

67.1 (65.8–68.4)

64.6 (62.5–66.6)

69.1 (67.4–70.7)

0.001

 Awareness

2003

59.4 (57.7–61.0)

54.3 (51.7–57.0)

62.9 (60.8–65.0)

< 0.001

 Treatment

1113

33.0 (31.4–34.6)

30.8 (28.3–33.2)

34.5 (32.5–36.6)

0.022

 Control A^b

226

20.3 (17.9–22.7)

21.8 (17.9–25.7)

19.4 (16.4–22.4)

0.335

 Control B^b

226

6.7 (5.9–7.5)

6.7 (5.4–8.0)

6.7 (5.6–7.8)

0.991

 Prevalence

722

14.4 (13.4–15.3)

11.6 (10.2–12.9)

16.5 (15.1–17.8)

< 0.001

 Awareness

583

80.7 (77.9–83.6)

72.3 (66.7–77.9)

85.2 (82.0–88.4)

< 0.001

 Treatment

240

33.2 (29.8–36.7)

32.1 (26.3–38.0)

33.8 (29.6–38.1)

0.645

 Control A^b

89

37.1 (30.9–43.2)

33.8 (21.2–44.3)

38.8 (31.1–46.4)

0.450

 Control B^b

285

39.5 (35.9–43.1)

32.5 (26.7–38.4)

43.1 (38.7–47.6)

0.006

 Prevalence

761

15.1 (14.2–16.1)

9.8 (8.5–11.0)

19.2 (17.7–20.6)

< 0.001

 Awareness

193

25.4 (22.3–28.5)

27.1 (21.1–33.2)

24.7 (21.1–28.3)

0.486

 Treatment

262

34.4 (31.1–37.8)

54.8 (48.0–61.6)

26.7 (23.0–30.4)

< 0.001

 Control A^b

248

94.7 (91.9–97.4)

95.7 (91.9–99.4)

93.9 (90.0–97.8)

0.526

 Control B^b

248

32.6 (29.3–35.9)

52.4 (45.6–59.2)

25.1 (21.4–28.7)

< 0.001